CVVH in Europe

28

description

CVVH in Europe. CVVH in Europe. All Sorts of Trouble and Complications. CVVH Experience in Hannover 7-1997 to 3-2002. CVVH Machine. Solutions for Substitution. SH19*SH39 Hep* - PowerPoint PPT Presentation

Transcript of CVVH in Europe

Page 1: CVVH in Europe
Page 2: CVVH in Europe

Hannover

Herrenhausen

New City Hall Kestner Museum

Sprengel MuseumOld City HallIndustrial Fairs

CEBIT

Page 3: CVVH in Europe

CVVH in EuropeCVVH in Europe

Page 4: CVVH in Europe

All Sorts of Trouble and Complications

CVVH Experience in Hannover 7-1997

to 3-2002

Page 5: CVVH in Europe

CVVH Machine

Page 6: CVVH in Europe

Solutions for Substitution

SH19* SH39 Hep*Na 140 145 mmol/lK 1 0 mmol/lCa 1.63 1.55 mmol/lMg 0.75 0.52 mmol/lCl 100.75 113.64 mmol/lLactate 45 - mmol/lBicarbonate - 36 mmol/lGlucose 1.96 1.04 g/l *Schiwa

Page 7: CVVH in Europe

Patients

Patients 32

Male/ Female 18 / 14

Age* [years] 5.3 (2 days - 19)

Weight* [kg] 14.1 (3.3 - 88)

BSA [m2] 0.63 (0.22 - 1.97)

*median (range)

Page 8: CVVH in Europe

Groups of Patients

Septicemia 12

Liver failure 9

Cardiac Disease 5

Renal Disease 3

Hyperammonemia 3

Page 9: CVVH in Europe

Solutions for Substitution

Schiwa SH39-Hep N 24

Schiwa SH 19 8

Page 10: CVVH in Europe

Filters Used

Diafilter 20 20

Minifilter plus 4

Minifilter /D20 5

Hemofilter 6S 3

Page 11: CVVH in Europe

Blood and Dialysate Flow

Blood flow [ml/kg/min] 3.1 (0.6 - 17.2)

Exchange rate [ml/m2/h] 475 (189 -1505)

Negative balance [ml/kg/h] 4.2 (0 - 17)

Page 12: CVVH in Europe

CAVH Urea

0 1 2 4 8

Page 13: CVVH in Europe

Ultrafiltration

8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 >300

1

2

3

Total Ultrafiltration [ml/min/1.73m ]2

Page 14: CVVH in Europe

Number Filters Used

1 2 3 4 5 6 7 8 9 10 11 12 13 140

12

3

45

6

78

9

Number of Filters Used

Page 15: CVVH in Europe

Filters clot

43/140 were lost this way (30.3%)

Page 16: CVVH in Europe

Duration of CVVH and Filter Survival

Total duration of CVVH [h] 56.5 (3 - 422)Number of filters 140„Survival“ of filter [h] 22.4(0.5 - 87)Reason for loss deliberate change 44of a filter clotting 43

operation/ CT scan 16end of CVVH 27technical problems 5plasmapheresis 5

Page 17: CVVH in Europe

Technical Problems

Switching between the 2 lines of the access 4

Necessity to replace access 2

3 Lumen oncologic catheter (Clearance 11) 1

Page 18: CVVH in Europe

Renal Disease (3/3)

Severe Hypertension

during recurrent HUS 1

Bilateral Nephrectomy during PD

in an infant 1

ATN after renal Tx 1

Page 19: CVVH in Europe

Hyperammonemia (1/3)

All 3 newborns received CVVHD

Defect CNS involvement Ammonia [µmol/l]

Citrullinemia mild encephalopathy 842 360

Citrullinemia severe encephalopathy 802 223

CPS def. cerebral edema 900 850

Page 20: CVVH in Europe

Heart Disease (1/5)

TGA with Rastelli operation,

bradyarrhythmias 2

Bradyarrhythmias 1

Pulmonary atresia with interventional

opening of the outflow tract 1

Penetrating heart trauma with a bicycle 1

Page 21: CVVH in Europe

Liver Disease (3/9)

Liver transplantation (3 acute LF) 7

Acute liver failure, no TX 2

Complicating factors

Re-transplantation 2

Portal vein thrombosis 2

CNS symptoms (seizure, edema) 2

Severe rejection (plasmapheresis) 1

Destruction of liver and spleen (horse kick) 1

Page 22: CVVH in Europe

Septicemia(4/12)

Bone MarrowTransplant 2

Oncologic patient 2

Heart/lungTx in CF, Liver Tx

Waterhouse-Friedrichsen Sy., Schwachman

Familial medit. Fever (amyloidosis) SCID

Premature with NEC Septic RF

1 each

Page 23: CVVH in Europe

Causes of Death

Multiple organ failure 8

Circulatory failure 4

Brain death 3

Liver failure 2

Rhabdomyolysis 2

Complete bowel necrosis 1

Page 24: CVVH in Europe

Major Complications

Arterial hypotension 15 / 32

Bleeding 3

Thrombosis iliac vein 1

Page 25: CVVH in Europe

Stenosis of Internal Jugular VeinStenosis of the Internal Jugular Vein

Page 26: CVVH in Europe

CAVH Results

Page 27: CVVH in Europe

Intensive Care and Dialysis

Total Death %

Cases in intensive care 938 35 4

LTx 15 (24), NTx 18 (31)

ICU patients dialysed 24 2.5

Dialysis 24 9 38

CVVH 9 4

PD 14 5

HD 1 0

Page 28: CVVH in Europe

Conclusion

CVVH broadens the array of treatment options in acute renal failure. It allows easier management through better fluid and solute clearances. However, this does not appreciably improve survival. Still, the original disease determines the prognosis - with renal failure being an negative predictor.